Monstar Lab, Inc.
Monstar Lab, Inc. (5255.T) Financial Performance & Income Statement Overview
Review Monstar Lab, Inc. (5255.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Monstar Lab, Inc. (5255.T) Income Statement & Financial Overview
Explore comprehensive income reports for Monstar Lab, Inc. 5255.T, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.06B | $2.22B | $2.54B | $3.18B |
| Cost of Revenue | $1.45B | $1.96B | $2.67B | $2.51B |
| Gross Profit | $612.03M | $265.97M | -$124.15M | $671.50M |
| Gross Profit Ratio | $0.30 | $0.12 | -$0.05 | $0.21 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.50B | $1.31B | $1.84B | $1.58B |
| Operating Expenses | -$1.36B | $5.17B | $1.84B | $1.56B |
| Total Costs & Expenses | $88.38M | $7.12B | $4.50B | $4.07B |
| Interest Income | $0.00 | $0.00 | $652.40M | $658.21M |
| Interest Expense | $0.00 | $0.00 | $34.80M | $33.29M |
| Depreciation & Amortization | $77.48M | $53.64M | $96.56M | $108.98M |
| EBITDA | -$2.43B | -$722.35M | -$5.35B | -$124.40M |
| EBITDA Ratio | -$1.18 | -$0.33 | -$2.10 | -$0.04 |
| Operating Income | $1.97B | -$4.90B | -$1.96B | -$891.59M |
| Operating Income Ratio | $0.96 | -$2.21 | -$0.77 | -$0.28 |
| Other Income/Expenses (Net) | -$4.01B | $2.87B | -$3.54B | $623.59M |
| Income Before Tax | -$2.04B | -$2.03B | -$5.50B | -$268.91M |
| Income Before Tax Ratio | -$0.99 | -$0.91 | -$2.17 | -$0.08 |
| Income Tax Expense | $172.03M | $177.03M | $58.39M | $79.64M |
| Net Income | -$2.21B | -$1.84B | -$5.55B | -$340.63M |
| Net Income Ratio | -$1.07 | -$0.83 | -$2.18 | -$0.11 |
| EPS | -$60.47 | -$53.64 | -$161.78 | -$9.92 |
| Diluted EPS | -$60.45 | -$53.64 | -$161.78 | -$9.92 |
| Weighted Avg Shares Outstanding | $36.58M | $34.33M | $34.33M | $34.34M |
| Weighted Avg Shares Outstanding (Diluted) | $36.59M | $34.33M | $34.33M | $34.34M |
Over the last four quarters, Monstar Lab, Inc.'s revenue moved from $3.18B in Q1 2024 to $2.06B in Q4 2024. Operating income in Q4 2024 was $1.97B, with a strong operating margin of 96%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Monstar Lab, Inc. remained robust at -$2.43B, reflecting operational efficiency. Net income dropped to -$2.21B, with an EPS of -$60.47. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan